Prevest Denpro Q4 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
N/A
Margin
N/A
Fundraise
N/A
Order
N/A
Capex
N/A
0 of 0 growth signals are positive — mixed outlook.
Full analysisRevenue guidance
See what Prevest Denpro management said on margin guidance — free account, 30 seconds.
Fundraise plans
See what Prevest Denpro management said on order book — free account, 30 seconds.
Capex plans
Track Prevest Denpro — get its next earnings analysis in your feed
How does Prevest Denpro rank vs peers in Healthcare Equipment & Supplies?
Pro featureHow does Prevest Denpro rank in Healthcare Equipment & Supplies?
Compare Prevest Denpro against every Healthcare Equipment & Supplies company (Q4 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Prevest Denpro's management said in earlier quarters
Others in Healthcare Equipment & Supplies this season
- Aprameya Enginee (Q2 FY26)
H1FY26 Revenue from Operations: Rs 421.4 Mn, up 343% YoY from Rs 92.7 Mn in H1FY25. Key investor presentation takeaways from Aprameya Engineering Ltd's Q2 FY26
- QMS Medical Allied Services Ltd (Q3 FY26)
Q3FY26 Revenue from Operations: ₹37.3 crore . Key investor presentation takeaways from QMS Medical Allied Services Ltd's Q3 FY26 investor presentation — and how
- Vaidya Sane (Q4 FY26)
170-180 crores driven by higher patient additions, increased hospital utilization, and franchise clinic growth. Key concall takeaways from Vaidya Sane Ayurved…
- Avience Biomedicals Ltd (Q1 FY27)
New manufacturing facility has capacity to support peak revenue of around ₹250–265 crore, subject to product mix and approvals. Key concall takeaways from…